Global funding shortages and challenges in ensuring adherence to treatment are threatening to delay or even derail new recommendations that all HIV patients begin antiretroviral drug therapy as soon as they are diagnosed. Read more.
Foreign Correspondent
Global funding shortages and challenges in ensuring adherence to treatment are threatening to delay or even derail new recommendations that all HIV patients begin antiretroviral drug therapy as soon as they are diagnosed. Read more.